Literature DB >> 22879730

Topical diphencyprone as an effective treatment for cutaneous metastatic melanoma.

Young Jin Kim1.   

Abstract

Entities:  

Year:  2012        PMID： 22879730      PMCID： PMC3412255          DOI： 10.5021/ad.2012.24.3.373

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  10 in total

Review 1.  Intralesional agents in the management of cutaneous malignancy: a review.

Authors:  Laurie M Good; Misha D Miller; Whitney A High
Journal:  J Am Acad Dermatol       Date:  2010-03-23       Impact factor: 11.527

2.  Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma.

Authors:  Uwe Trefzer; Wolfram Sterry
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

3.  Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone.

Authors:  Diona L Damian; John F Thompson
Journal:  J Am Acad Dermatol       Date:  2007-02-05       Impact factor: 11.527

4.  Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine.

Authors:  C C Harland; E M Saihan
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

5.  Restoration of tumor equilibrium after immunotherapy for advanced melanoma: three illustrative cases.

Authors:  Sofie Wilgenhof; Lauranne Pierret; Jurgen Corthals; An M T Van Nuffel; Carlo Heirman; Truus Roelandt; Arlette De Coninck; Guy Verfaillie; Frederik Vandenbroucke; Ivan Van Riet; Aude Bonehill; Kris Thielemans; Bart Neyns
Journal:  Melanoma Res       Date:  2011-04       Impact factor: 3.599

Review 6.  Haptens as drugs: contact allergens are powerful topical immunomodulators.

Authors:  Aton M Holzer; Leonard L Kaplan; William R Levis
Journal:  J Drugs Dermatol       Date:  2006-05       Impact factor: 2.114

Review 7.  Melanoma: from darkness to promise.

Authors:  Joan Manel Gasent Blesa; Enrique Grande Pulido; Vicente Alberola Candel; Mariano Provencio Pulla
Journal:  Am J Clin Oncol       Date:  2011-04       Impact factor: 2.339

8.  TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.

Authors:  Frank Martiniuk; Diona L Damian; John F Thompson; Richard A Scolyer; Kam-Meng Tchou-Wong; William R Levis
Journal:  J Drugs Dermatol       Date:  2010-11       Impact factor: 2.114

9.  Melanoma epidemiology and trends.

Authors:  Claus Garbe; Ulrike Leiter
Journal:  Clin Dermatol       Date:  2009 Jan-Feb       Impact factor: 3.541

10.  Topical diphencyprone immunotherapy for cutaneous metastatic melanoma.

Authors:  Diona L Damian; Kerwin F Shannon; Robyn P Saw; John F Thompson
Journal:  Australas J Dermatol       Date:  2009-11       Impact factor: 2.875
  10 in total
  3 in total

Review 1.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

Review 2.  Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity.

Authors:  Dan A Erkes; Senthamil R Selvan
Journal:  J Immunol Res       Date:  2014-05-15       Impact factor: 4.818

Review 3.  Nonsteroidal Topical Immunomodulators in Allergology and Dermatology.

Authors:  Marina Jovanović; Zoran Golušin
Journal:  Biomed Res Int       Date:  2016-04-06       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.